Nicole M. Bzdyl

ORCID: 0000-0003-2204-1172
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacterial Identification and Susceptibility Testing
  • Burkholderia infections and melioidosis
  • Signaling Pathways in Disease
  • Peptidase Inhibition and Analysis
  • Toxin Mechanisms and Immunotoxins
  • Research on Leishmaniasis Studies
  • Antimicrobial Resistance in Staphylococcus
  • Streptococcal Infections and Treatments
  • Trypanosoma species research and implications
  • Antibiotic Resistance in Bacteria
  • Escherichia coli research studies
  • Clostridium difficile and Clostridium perfringens research
  • Galectins and Cancer Biology
  • Enterobacteriaceae and Cronobacter Research
  • Calcium signaling and nucleotide metabolism
  • Amoebic Infections and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Antimicrobial Peptides and Activities
  • Antibiotics Pharmacokinetics and Efficacy

The University of Western Australia
2015-2024

Queen Elizabeth II Medical Centre
2018

Pathwest Laboratory Medicine
2015

The expanding global distribution of multi-resistant Klebsiella pneumoniae demands faster antimicrobial susceptibility testing (AST) to guide antibiotic treatment. Current ASTs rely on time-consuming differentiation resistance and after initial isolation bacteria from a clinical specimen. Here we describe flow cytometry workflow determine carbapenem bacterial cell characteristics in an international K. isolate collection (n = 48), with range carbapenemases. Our cytometry-assisted test (FAST)...

10.1038/s41598-017-02009-3 article EN cc-by Scientific Reports 2017-05-09

<title>Abstract</title> Group A <italic>Streptococcus</italic> (GAS) has remained universally susceptible to penicillin since the introduction of this antibiotic treat GAS throat infections (“Strep throat”) in 1940’s. Despite this, a proportion Strep fail completely resolve with therapy, recurrent requiring follow-up treatment alternative broad-spectrum antibiotics. Here we show that strains isolated from amoxicillin failures are able invade into epithelial cells and replicate presence...

10.21203/rs.3.rs-1602989/v1 preprint EN Research Square (Research Square) 2025-05-02

The facultative anaerobic Gram-negative species Escherichia albertii has been isolated from human faeces in gastrointestinal infection and a range of wild bird species. Here we report the first case febrile associated with E. bacteraemia 76-year-old woman gastric dysplasia.

10.1016/j.nmni.2015.07.003 article EN cc-by New Microbes and New Infections 2015-07-16

Coxiella burnetii is a Gram-negative intracellular pathogen that causes the debilitating disease Q fever, which affects both animals and humans. The only available human vaccine, Q-Vax, effective but has high risk of severe adverse reactions, limiting its use as countermeasure to contain outbreaks. Therefore, it essential identify new drug targets treat this infection. Macrophage infectivity potentiator (Mip) proteins catalyse folding proline-containing through their peptidyl prolyl...

10.1371/journal.ppat.1011491 article EN cc-by PLoS Pathogens 2023-07-03

Abstract Background The macrophage infectivity potentiator (Mip) protein, which belongs to the immunophilin superfamily, is a peptidyl-prolyl cis/trans isomerase (PPIase) enzyme. Mip has been shown be important for virulence in wide range of pathogenic microorganisms. It previously demonstrated that small-molecule compounds designed target from Gram-negative bacterium Burkholderia pseudomallei bind at site enzymatic activity inhibiting vitro Mip. Objectives In this study, co-crystallography...

10.1093/jac/dkac065 article EN cc-by-nc Journal of Antimicrobial Chemotherapy 2022-02-23

The macrophage infectivity potentiator (Mip) protein is a promising target for developing new drugs to combat antimicrobial resistance. New rapamycin-derived Mip inhibitors have been designed that may be able combine two binding modes inhibit the of Burkholderia pseudomallei (BpMip). These novel compounds are characterized by an additional substituent in middle chain linking lateral pyridine pipecoline moiety, constituting different stereoisomers. demonstrated high affinity BpMip nanomolar...

10.1021/acs.jmedchem.3c00458 article EN Journal of Medicinal Chemistry 2023-06-30

Burkholderia pseudomallei is the causative agent of melioidosis, a disease endemic to Southeast Asia and northern Australia. Mortality rates in these areas are high even with antimicrobial treatment, there few options for effective therapy. Therefore, need identify antibacterial targets development novel treatments. Cyclophilins family highly conserved enzymes important multiple cellular processes. catalyze cis-trans isomerization xaa-proline bonds, rate-limiting step protein folding which...

10.1128/iai.00528-19 article EN Infection and Immunity 2019-07-23

The treatment of Chagas disease and infections with Gram-negative bacteria is limited to a low number antibiotics. Due the development resistance partially severe side effects, there an urgent need for new strategies virulence factors such as macrophage infectivity potentiator (MIP) protein have emerged promising therapeutic target. Inhibition microbial MIP proteins leads reduced viability proliferation in pathogens Legionella pneumophila Burkholderia pseudomallei. parasitic pathogen...

10.26434/chemrxiv-2024-jk23r preprint EN cc-by-nc-nd 2024-05-27

Rapid identification of bacteria isolated from blood cultures by direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is now in wide spread use major centres but not yet feasible smaller hospital laboratories. A FilmArray multiplex PCR panel for culture isolate (BCID) provides an alternative approach to near point-of-care microbial regional hospitals. We assessed the accuracy and time BCID a consecutive series 149 143 patients teaching hospitals,...

10.1099/jmm.0.000194 article EN Journal of Medical Microbiology 2015-10-27

Purpose. In this field trial of rapid blood culture identification (BCID), we aimed to determine whether the improved speed and accuracy specific BCID predicted in our earlier pilot study could be obtained regional hospitals by deploying a multiplex PCR FilmArray (Biomerieux, France) capability their laboratories.Methods. We trained local hospital laboratory staff operate equipment act on results. To do this, integrated into standard workflow reporting procedure.Results. Of 100 positive...

10.1099/jmm.0.000714 article EN Journal of Medical Microbiology 2018-03-13

Introduction Melioidosis, caused by the Gram-negative bacterium Burkholderia pseudomallei , is a disease endemic in many tropical countries globally. Clinical presentation highly variable, ranging from asymptomatic to fatal septicemia, and thus outcome of infection can depend on host immune responses. The aims this study were firstly, characterize macrophage response B. secondly, determine whether was modified presence novel inhibitors targeting virulence factor, infectivity potentiator...

10.3389/fcimb.2024.1353682 article EN cc-by Frontiers in Cellular and Infection Microbiology 2024-03-25
Coming Soon ...